Soleno Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 02/13/2025 | 6.29 M | $282.82 M | 0.00% | 15.02% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 5.19 M | $233.13 M | 27.13% | 12.39% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 3.93 M | $176.61 M | 20.14% | 9.38% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.78 M | $124.78 M | -16.44% | 6.63% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 2.53 M | $113.50 M | 15.77% | 6.03% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.01 M | $90.34 M | -0.10% | 4.80% |
| VANGUARD GROUP INC | 02/11/2025 | 1.88 M | $84.71 M | 19.22% | 4.50% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.63 M | $73.30 M | 24.53% | 3.89% |
| COMMODORE CAPITAL LP | 02/14/2025 | 1.53 M | $68.55 M | 21.03% | 3.64% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.51 M | $67.92 M | 2,070.98% | 3.61% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.50 M | $67.47 M | -53.17% | 3.58% |
| CARLYLE GROUP INC. | 02/13/2025 | 1.38 M | $61.75 M | -66.21% | 3.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.13 M | $50.74 M | 213.67% | 2.70% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.06 M | $47.65 M | 47.22% | 2.53% |
| HOLOCENE ADVISORS, LP | 02/14/2025 | 955,467 | $42.95 M | 60.75% | 2.28% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2025 | 881,460 | $39.62 M | 77.82% | 2.10% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 851,838 | $38.29 M | 47.99% | 2.03% |
| FMR LLC | 02/13/2025 | 813,027 | $36.55 M | 22.19% | 1.94% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 782,265 | $35.16 M | 14.51% | 1.87% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 776,300 | $34.89 M | 274.48% | 1.85% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 757,248 | $34.04 M | 29.15% | 1.81% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 699,159 | $31.43 M | -20.16% | 1.67% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 599,119 | $26.94 M | 10.89% | 1.43% |
| EMERALD ADVISERS, LLC | 02/11/2025 | 580,919 | $26.11 M | 85.40% | 1.39% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 550,000 | $24.72 M | 0.00% | 1.31% |
| ARTIA GLOBAL PARTNERS LP | 02/14/2025 | 494,424 | $22.22 M | 80.17% | 1.18% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 476,801 | $21.43 M | 87.06% | 1.14% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 438,500 | $19.71 M | 43,750.00% | 1.05% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 424,081 | $19.06 M | -56.55% | 1.01% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 419,443 | $18.85 M | 15.50% | 1.00% |
| MARSHALL WACE, LLP | 02/13/2025 | 399,849 | $17.97 M | 61.33% | 0.95% |
| SAMLYN CAPITAL, LLC | 02/14/2025 | 378,103 | $17.00 M | -26.12% | 0.90% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/14/2025 | 368,574 | $16.57 M | 58.18% | 0.88% |
| SIREN, L.L.C. | 02/14/2025 | 351,818 | $15.81 M | 100.00% | 0.84% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 350,000 | $15.73 M | 100.00% | 0.84% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/03/2025 | 339,774 | $15.27 M | 100.00% | 0.81% |
| PFM HEALTH SCIENCES, LP | 02/14/2025 | 307,503 | $13.82 M | 100.00% | 0.73% |
| WOODLINE PARTNERS LP | 02/14/2025 | 301,562 | $13.56 M | -25.00% | 0.72% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 02/18/2025 | 299,244 | $13.45 M | 100.00% | 0.71% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 261,325 | $11.75 M | 100.00% | 0.62% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 250,000 | $11.24 M | 17.42% | 0.60% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 217,550 | $9.78 M | 12.96% | 0.52% |
| 02/14/2025 | 175,400 | $7.88 M | 100.00% | 0.42% | |
| JANE STREET GROUP, LLC | 02/14/2025 | 144,200 | $6.48 M | 166.54% | 0.34% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 130,000 | $5.84 M | 420.00% | 0.31% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/29/2025 | 128,028 | $5.75 M | -9.47% | 0.31% |
| BARCLAYS PLC | 02/13/2025 | 126,675 | $5.69 M | 141.08% | 0.30% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 02/25/2025 | 125,400 | $5.64 M | 296.84% | 0.30% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 124,095 | $5.58 M | 100.00% | 0.30% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 119,455 | $5.37 M | 44.82% | 0.29% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Soleno Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 178 institutional investors and hedge funds held shares of Soleno Therapeutics, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 6.29 M
JANUS HENDERSON GROUP PLC: 5.19 M
Nantahala Capital Management, LLC: 3.93 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.78 M
Avoro Capital Advisors LLC: 2.53 M
BlackRock Funding, Inc. /DE: 2.01 M
121.87% of Soleno Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 51.58 M shares in the last 24 months. This purchase volume represents approximately $2.37 B in transactions.